NSEUpdates1d ago · 17 Sept 2026, 04:56 pm

Updates

Fischer Medical Ventures Limited · FISCHER

✦ AI SummaryResults

Fischer Medical Ventures Limited has informed the Exchange regarding 'Presentation of Investor/Analyst meeting' and submitted a revised presentation as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Limited has informed the Exchange regarding 'Presentation of Investor/Analyst meeting'.

Attachments (1)

📄

FISCHER_17092026165507_Revised_Presentation_to_SE_17092026.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 September 17, 2026 To To BSE Limited National Stock Exchange of India Ltd. Exchange Corporate Relationship Department Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001 Mumbai - 400 051 BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/ Madam, Sub: Submission of revised presentation as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to our presentation dated September 7, 2026 in terms of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed copy of the revised presentation for the Investor/Analyst call held on September 7, 2026. This is for the information of the exchange and the members. Thanking you, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY AND COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 INVESTOR& STRATEGPIACR TNERSHIPPR ESENTATION Fischer MedLiimciatle dV entures Builtdhiweno gr llda'rsg est HealtAhlSc oalruePt liaotfonrsm Al-enMaebdlieIcdma alg IiPn ogup latioSnc-rseceaInlHi eosn ipgt Dailg itization June 2026 Confnitldi DeaoI Not Distribute LEGALN OTICE Disclaimer InformMaetmioorna npdruemp afroeFrdi scher Medical Ventures Limited PREPARBEYD FiscMheedri Vceanlt ures • Purp&oS sceo pe • DuDei lig&e nRcAiecs kkn owledgement Potenitnivaels tsotrsr aaptnaedrtg niaecrr aesd vitsoe dp etrfhoeoriwmrn d udei ligaencndoc nes ult Thei nformpartioovnii tnd heIidns f ormMaetmioorna nidfsuo imron rfmatipounraplo ses witqhu alfiifniaenldce igoaarill n, v estamdevnibtse ofromsra ek ianndgye cisbiaosonensdt he onlanyds hounolt bde c onsidaneo rffereo drs olciitatot enigoangi nae n iyn vestment contoefnt thpsir se senItnavteisotnim.nhe enatlst theccahrneom leodgiiycm,aa lg ainnAdgl -enabled or fintarnacnisaarellc attitoeoF dni scher MedicalT hVimesen motraunrdeusm Limdiitaegdnp.ol sattificon rhmesrc eanrrtryil syak nspd,a psetrf onremieans o atr eliianbdlieoca ftf ourt ure has benep repaerd byF sicher Medurisec aLli mtoVi oetffneeatdcr o mprehensive resultsc.o nMdairrtkeiegotun lsfa,rt aomrye waonrtdke sc hncyocllocegasycn h anrgaep idly, overvoifie tbwsu sinessa,n dpp elorarftmfaon-rc bmuet i nso ti enntdetdos ervea sa impacbtuisnigon uetscso amnefdsi nancial returns. standailnovnees tment guide. • Accur&a Pcrye limEisntairmya tes • LimitoafLt iiaobni lity WhileF ischer Muerdsei cLailsm tiVrteifenvdoate rcs c urinat chpyer esenotfa tion Iti ess senttoai cakln owtlhetvad agrei asbulcaehsms a kreftul ctuarteigounlsa,t ory finandcaitaraldo, u cdpte tarielgsu,la aptopovrrya alndsm arkientf ormaalftlii gounr,e s changpersjeoc,tt i melainnuden sf oreospeeerna tcihoanlalclea n ingneflsu ethnec e andst atiasrtei csstuo bc jheacnwtgi et hporruin too tiAncy per.o vifidneadn ecsitailm ates compapneyrfo'rsm anFcsicehe.r Medical Vaendn its tuarsescisota eeLdni timieitst ed aerp rleiminard ysh oaunnlodtb ei ntreertapesfid n l aofferTsh.eu ltiamtfiena nctiearlm s discla liima bfoairnil yniatcyc uormaiscisioenosrst, y pograerprhotirhcsmaa atl yb e wil ble detearttmh ietn iemodf ef romalc ontargaerecmte nt. presenti n dtohcieusnmt. Bya ccestshidinosgc ument, atchkneo wrleaedndpadgic eecesnpt tth tsee nnssefo tr tahb o.v e June 2026 ConfidIeDnot iNDaoilts tribute DISRUPTIVTEE CHNOLOGIES ProprietarSyt aTcekc hnology Six pillarbse spto-wiienmr-aicgpnlieganrf sgos r mance A WhyoO lwlned Subosfi/'d EJ!ia£!!!!r!y 0 0 0 Magnet Technology RF TCeocihln ology ConsToelceh nology ■ Perma&n eLTn0St. 35T/ ■ Multi-channel phased ■arraUynifsiceadnp nliantgf orm 0.71T./S T/3.0T ■ Multi-fnruecqluceeoini clys ■ Remodtiea gsnuoposprtis ■ Cryogemna-gfnreetes ■ HTS coil architecture ■ AdvanGcUewIdo rkflow ■ HTuStl ra-fhiieglhd Imaging TechnologyG radTieecnhtn ology AlT echnology ■ Fasstceatrmni e s ■ Al-assiimsatgeidn g ■ High-pergfroardmiaennctes ■ Higrheesro lution ■ Autsoc anning ■ Fasitmearg ciyncgl es ■ Noirseed uc&ta idoanpf tiilvtee r ■ Pre-drieaagdn ostics KEY TAKEAVWeArYt iicnatlelgyrI aPat cerdom sasg nectosig,lr sa,d iceonntssoi,lm aeg,ai nndAg l - a defenasgiabiclnoesm tmm oodaitt ized OEMs. June 2026 ConfidIDe on tDNiioastlt ribute DIRECTORS FMV List of Directors Board of Directors Whole Time Director Chairman & Managing Director Independent Director Svetlana Rao Raviwada Ravindran Govindan Khairy Jamaluddin Abu Bakar • Electronics & Communications Engineer with prior • Former Chairman & President (APAC), Fisher Scientific • Former Minister of Health, Malaysia roles at Wipro & Alcatel R&D Inc. • Led national COVID-19 response and digital healthcare • Led establishment of FMV India operations • 45+ years across healthcare, investments & technology initiatives • Oversees India business strategy and operations • Early investor and strategic advisor to Time Medical • Brings Southeast Asian healthcare policy and Group governance expertise June 2026 Confidential | Do Not Distribute DIRECTORS FMV List of Directors Board of Directors Independent Director Independent Director Independent Director Ms. Jaya Ankur Singhania Mr. Richard Chan Sing En Dr. Syed Jalaluddin • 15+ years in corporate governance and legal advisory • 30+ years in private equity and corporate finance • Distinguished academic, scientist & corporate leader • Expertise in compliance, CSR, IP rights & board • Extensive experience across Southeast Asia & Australia • Contributor to Malaysia's halal ecosystem and Islamic governance • Provides strategic financial and investment advisory banking sector • Supports regulatory oversight and governance insights • Brings deep technical, scientific and governance frameworks expertise June 2026 Confidential | Do Not Distribute DIRECTORS FMVKMP KeMya nagerial Personal- FMV Group FMVG roCuhpiO epfe rating FMGVr oupF iCnhainecfi al ChiTeechfn olOoffgiycTi emre- Chief OOfpfiecreTiarmt-eMi endgi cal Officer Officer Medical Shankar VajarnadharaVivBeakl asubramanian SimYoenu ng AmoMlh askar • 30y+e airnis ns vtement • CharteAcroceutdnna tw ith, • Co-foouTfni dmMeeer d ical•Ovre y1e3a orefsx e prtiisnFe id el bankijnetgcf ,i nparnocingh,avgpi ernviowuosrlkayetP dW C Systweimotsveh 2r 0 y eaorfs Engeirnisenpge,c iiaMnlR iIz eismnsyg,s t ansdt ralteeeagrdsihci p adn KPaMsaGl eiaMnde rgers experiinMe RnsIcy es tem porjemcatn amgeenatn,cd u stosmeerrv ice, • Exrpieeea nccrsoescst ors andA cquitseiatmi.ons develowpimteehxn tte,n sivweiatfo hc uosnm eetdienagd aldnines inclbuadnikntigeen lcgo,m , • Heh sa a tsrtarrcoeknc ogof rd operatcioomnmael,ar, nc dial driignov preatisocuencsasl. tecphwo,ee rt c. succeasdsvfiuisdlniale snlyfo g r idnusterxipaelra icernocses •Succfeulslesladynm den torteaedm osf laediPnEgVs Cs, acnodor rpations haehlctamraer ski etnth UeS A, FideE lgnineMeanrietsan,n cTceenh icians, int hIesT, t uaprastn adu toobmile Eur&oC phei na. optimriseuzoricuneltg ii zaantdion sectors. improevffiincgi ency June 2026 ConfidIDe on tDNiioastlt ribute